Ferring and Pharmabiome Enter A Microbiome R&D Collaboration and Licensing Agreement
Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are announcing a research & development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology. The deal provides Ferring with exclusive rights to develop, manufacture and commercialise next generation…
Evonetix Announce Agreement for Gene Synthesis Platform with Analog Devices
Evonetix have announced the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc. (ADI), a global semiconductor leader. This agreement signals the continuation of the long-standing combined work of both companies, bringing efforts to the next stage…
Körber and LabWare Pave Way MES-LIMS Integration
Körber and LabWare have announced a significant advancement in their partnership, achieving the “Ready” level required for LabWare to join Körber’s Ecosystem of partner companies. This collaboration reinforces the seamless integration capabilities between LabWare’s Laboratory Information Management System (LIMS) and Körber’s Manufacturing Execution…
Innovent Biologics and Synaffix Expand ADC Collaboration
Synaffix, a Lonza company, announces the expansion of its licensing agreement with Innovent Biologics, a biopharmaceutical company that develops, manufactures and commercialises high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases. Building on the core value proposition of Synaffix…
Vesper Bio Doses First Volunteer in Phase I Study for Frontotemporal Dementia
Vesper Bio ApS announces that the first volunteer has been dosed with its lead compound VES001, a patient friendly, first-in-class, brain penetrant, oral treatment, that could bring a meaningful disease-modifying benefit to patients suffering from Frontotemporal Dementia harbouring loss of function…
Aptar Pharma Opens New Mumbai Site
Aptar Pharma have announced the opening of its new Aptar Mumbai site, which will increase manufacturing capabilities in South East Asia. An inauguration ceremony held on December 1, 2023, marked the official opening of the new Aptar Mumbai production facility in…
AbbVie to Acquire Cerevel Therapeutics for $8.7 Billion
AbbVie Inc and Cerevel Therapeutics have announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its robust neuroscience pipeline of multiple clinical-stage and preclinical candidates with potential across several diseases including schizophrenia, Parkinson’s disease (PD), and mood disorders….
Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency
Gyros Protein Technologies AB and Biotage have announced a partnership to offer Biotage PeptiPEC, based on Gyros’ PurePep EasyClean (PEC) catch and release technology, on Biotage Extrahera automated sample preparation system. The development of an automated plate-based peptide purification workflow provides a fast and environmentally…
.jpg?cb=fda0471ce2110694009643ea2e41621c&w=1200)
The Complexities of Manufacturing Orphan Drugs in Product Development
Cornell Stamoran, Vice President, Strategy and Government Affairs and Matt Mollan, Vice President Operations at Catalent for our latest EPM Magazine issue. There are approximately 1,500 active pipeline compounds within orphan designation today, and, like the overall pharmaceutical pipeline, small molecules…
Early Cryopreservation as a Stepping Stone to Sustainable Cell and Gene Therapy Manufacturing
Priya Baraniak, Ph.D, Chief Business Officer and Dominic Mancini, VP Operations at OrganaBio explored early cryopreservation as a stepping stone to sustainable cell and gene therapy manufacturing in our latest EPM Magazine issue. Scalability and sustainability have become choke points for…